Clinical Trials Directory

Trials / Completed

CompletedNCT05274178

Effect of Hearing Aid Labeling on Speech Understanding Measures

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Sonova AG · Industry
Sex
All
Age
18 Years – 95 Years
Healthy volunteers
Accepted

Summary

New and experienced hearing aid users will be fit with two hearing devices. One will be labeled as an OTC (Over-The-Counter) device, the other will be labeled as a Prescriptive (i.e. professionally fit) device. Both devices will be generically programmed for a mild to moderate hearing loss. An objective speech in noise test will be completed with both devices.

Conditions

Interventions

TypeNameDescription
DEVICEAudeo P hearing aid labeled as "Prescriptive"The Audeo P is a commercially available hearing aid that is fit by a hearing care professional. The devices will be labeled as "prescriptive" in view of the participant.
DEVICEAudeo P hearing aid labeled as "OTC"The Audeo P is a commercially available hearing aid that is fit by a hearing care professional. The devices will be labeled as "OTC" in view of the participant.

Timeline

Start date
2022-05-26
Primary completion
2022-06-16
Completion
2022-06-16
First posted
2022-03-10
Last updated
2023-07-10
Results posted
2023-07-10

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT05274178. Inclusion in this directory is not an endorsement.

Effect of Hearing Aid Labeling on Speech Understanding Measures (NCT05274178) · Clinical Trials Directory